Reported
Lowest–highest estimate
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Dr Reddy's Laboratories Ltd
SWB:RDDA
Dr Reddy's Laboratories Ltd
SWB:RDDA
Price:
10.9
EUR
Market Cap:
€1.8B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
D
|
Dr Reddy's Laboratories Ltd
SWB:RDDA
|
IN |
|
OODA AI publ AB
STO:OODA
|
SE |
|
M
|
Minerals Technologies Inc
F:MNK
|
US |
|
B
|
Baxter International Inc
XMUN:BTL
|
US |
|
Solstad Maritime ASA
OTC:SLTMF
|
NO |
|
W
|
Wesfarmers Ltd
OTC:WFAFF
|
AU |
|
E
|
Everest Group Ltd
DUS:ERE
|
BM |
|
H
|
HCA Healthcare Inc
F:2BH
|
US |
|
Innate Pharma SA
F:IDD
|
FR |
|
J
|
JPMorgan Chase & Co
XHAN:CMC
|
US |
|
Ibiden Co Ltd
F:IBI
|
JP |
|
M
|
Meta Platforms Inc
DUS:FB2A
|
US |
|
F
|
Fielmann Group AG
DUS:FIE
|
DE |
|
N
|
Nexon Co Ltd
F:7NX
|
JP |
|
WillScot Holdings Corp
F:WS11
|
US |
Wall St Price Targets
RDDA Price Forecast
Based on 40 analysts
Based on 40 analysts
-1% Downside
from
€10.9
today
Dr Reddy's Laboratories Ltd (RDDA)’s 12-month stock price forecast through July 2027 has a consensus target of €10.79, implying 1% downside. The forecast is based on price targets from 40 Wall Street analysts.
RDDA Analyst Rating
No ratings yet
No ratings yet
Dr Reddy's Laboratories Ltd Competitors:
Price Targets
Price Targets
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is RDDA's stock price target?
Price Target
10.79
EUR
10.79
EUR
According to Wall Street analysts, the average 1-year price target for RDDA is 10.79 EUR with a low forecast of 9.09 EUR and a high forecast of 15.83 EUR.
What is the Revenue forecast for Dr Reddy's Laboratories Ltd?
Projected CAGR
8%
8%
Over the last 13 years, the compound annual growth rate for Revenue has been 8%. The projected CAGR for the next 5 years is 8%.
What is the Gross Profit forecast for Dr Reddy's Laboratories Ltd?
Projected CAGR
6%
6%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 8%. The projected CAGR for the next 5 years is 6%.
What is the Operating Income forecast for Dr Reddy's Laboratories Ltd?
Projected CAGR
17%
17%
Over the last 13 years, the compound annual growth rate for Operating Income has been 6%. The projected CAGR for the next 5 years is 17%.
What is the Pre-Tax Income forecast for Dr Reddy's Laboratories Ltd?
Projected CAGR
12%
12%
Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 7%. The projected CAGR for the next 3 years is 12%.
What is the Net Income forecast for Dr Reddy's Laboratories Ltd?
Projected CAGR
16%
16%
Over the last 13 years, the compound annual growth rate for Net Income has been 8%. The projected CAGR for the next 5 years is 16%.